What Stevenage Bioscience Catalyst does

Stevenage Bioscience Catalyst (SBC) is a UK-registered not-for-profit open innovation campus founded in 2012, headquartered on Gunnels Wood Road in Stevenage, Hertfordshire within the so-called Golden Triangle connecting London, Cambridge, and Oxford. It operates a multi-building life sciences campus (Incubator, Accelerator, Spark Building, Seed Works, and Lab Hotel) that supplies laboratory and office accommodation, shared scientific infrastructure, and wraparound business and scientific support services to approximately 45 therapeutics companies — making it the largest cluster of cell and gene therapy (CGT) companies in Europe. Major occupiers and partners include GSK, the Cell and Gene Therapy Catapult (which operates a £60m manufacturing centre on site with 12 collaborator units opened in April 2018), LifeArc, and Cytiva (which provides the only Cytiva Technology Lab of its kind in Europe with Biacore, ÄKTA, and Typhoon imaging equipment).

SBC's offering combines physical infrastructure with embedded ecosystem support. Shared scientific facilities include the Cytiva Technology Lab, a free-of-charge Community Lab with autoclaves, PCR, -80°C storage, and BMG ClarioStar plate reader, plus specialist pharma mentorship via the Catalyser Programme — a 3.5-day AI-powered strategy retreat run with Triple Chasm. Business support covers CEO roundtables, funding guidance, investor introductions, pitch workshops, and free One Nucleus membership. The Lab Hotel subsidises early-stage pre-Series A therapeutics start-ups with up to 250 sq ft of rent-free lab and office space for six months, with seven slots per cohort. The site employs 11–50 internal SBC staff (the wider campus supports over 4,000 life sciences jobs), and is funded through rental income, support service fees, and grants from public funders including Wellcome, Innovate UK, BEIS, and the Hertfordshire Local Enterprise Partnership (£1.55m received November 2019).

The business model is a hybrid real-estate-plus-services subscription: companies pay annual rent on incubator/accelerator/spark units (incubator up to 1,000 sq ft), supplemented by fees for business and science support services. Customer acquisition is community-led through alumni referrals, CEO roundtables, accelerator intakes, and partnerships with industry bodies (One Nucleus, Hertfordshire Futures, Triple Chasm). Since 2012, campus companies have collectively raised over £4bn in equity and recorded seven exits. SBC is led by Interim CEO and CFO Andrew Waters following the 2026 passing of founding CEO Dr Sally Ann Forsyth OBE, with Ian Tomlinson as Chairman, Marco Delise as Director of Business and Entrepreneurship, and Liz Hawley as Finance Director.

Name

Stevenage Bioscience Catalyst

Legal name

Stevenage Bioscience Catalyst

Website

https://stevenagecatalyst.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Stevenage Bioscience Catalyst is a UK not-for-profit open innovation campus, founded in 2012, providing laboratory and office accommodation plus business and scientific support to 45+ therapeutics companies, operating the largest cell and gene therapy cluster in Europe.

Ownership category

akta.pro rank

Product category

Life Science Incubator / Biomedical Campus Facilities

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Youth Business Incubators & Accelerators (EDAMAHAC)

Keywords

• Life science incubator
• Biomedical campus facilities
• Therapeutics lab space
• Cell and gene therapy
• Biotech accelerator programme

Headquarters

HQ city

Stevenage

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Laboratory and Office Accommodation: Rental income from laboratory and office space provision to life science companies. SBC provides various space options including Incubator, Accelerator, Spark Building, and Seed Works.
2. Business and Science Support Services: Provides wraparound business and science support including mentorship, funding guidance, access to facilities, and networking events to campus occupiers.
3. Accelerator Programme: Free Catalyser accelerator programme for therapeutics start-ups. The Lab Hotel provides rent-free space for 7 early-stage companies for 6 months.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Stevenage Bioscience Catalyst is a not-for-profit open innovation biomedical campus that provides laboratory and office accommodation, shared scientific facilities, and business/scientific support services to life sciences companies. The campus offers tiered spaces (Lab Hotel, Incubator, Accelerator, Spark Building, Seed Works) and world-class shared infrastructure including the Cytiva Technology Lab and the £60M Cell and Gene Therapy Catapult Manufacturing Centre.

Product overview

Stevenage Bioscience Catalyst is an open innovation campus providing laboratory and office accommodation for life science companies engaged in cutting-edge research. The offering consists of physical infrastructure facilities (Incubator Building, Accelerator Building, Spark Building, Seed Works, and Lab Hotel) that provide lab and office spaces ranging from 1,000 sq ft incubator units to larger bespoke accommodation, with the Spark Building specifically supporting cell and gene technology ventures. The campus also provides shared scientific facilities including the Community Lab (free to occupiers), the Cytiva Technology Lab (the only one of its kind in Europe), and the Cell and Gene Therapy Catapult Manufacturing Centre. Business and scientific support services complement the physical infrastructure, including the Catalyser Programme accelerator for therapeutics start-ups. Companies based on campus employ over 4,000 people and have raised over 4 billion pounds in funding.

Differentiator

Problem solved

Functional benefit

Brands

• Lab Hotel: Provides seven organisations with rent-free space for six months in the Incubator building for early-stage start-ups.
• Catalyser Programme

Products and services

• Lab Hotel Rent-free laboratory and office accommodation programme that houses up to 7 early-stage biotech start-ups for 6 months in the Incubator building. Each start-up receives approximately 250 sq ft of space, access to molecular biology and mammalian tissue culture equipment, two office desks, and shared access to the Community Lab and Cytiva Technology Lab. Selection criteria include developing therapeutics, wet-lab activity, and pre-Series A funding status.
• Incubator Building
• Accelerator Building
• Spark Building
• Seed Works
• Catalyser Programme
• Community Lab
• Cytiva Technology Lab
• Cell and Gene Therapy Catapult Manufacturing Centre World-leading manufacturing centre with 12 collaborator units, serving SMEs through to multinationals with equipment, specialists and supply chain to fast-track cell and gene therapies to patients.
• Business Support Services
• Scientific Support Services

Quantifiable outcome

• Companies based at SBC have raised over £4bn in funding since 2012
• +5 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and supporting.

• GSKcoreStrategic or Co-development PartnerMajor organisation based on campus sharing facilities including shuttle bus, restaurant, and gym. Provides access to scientific journals for occupiers. Located adjacent to SBC on Stevenage Campus.
• Cell and Gene Therapy Catapult (CGTC)coreStrategic or Co-development Partner£60 million manufacturing centre opened in 2018 with 12 collaborator units. Provides development, scale-up and commercialisation support for cell and gene therapies.
• LifeArccoreStrategic or Co-development PartnerMajor organisation based on campus contributing to the therapeutics ecosystem.
• CytivacoreTechnology or IntegrationProvides state-of-the-art Technology Lab equipment including VIA Freeze Uno, Biacore 8K+, Biacore T200, Amersham Typhoon 5, ÄKTA avant, and ÄKTA pure. Only Cytiva Technology Lab of its kind in Europe.
• Triple ChasmcoreStrategic or Co-development PartnerPartners with SBC for the Catalyser accelerator programme. Provides AI-powered strategy retreat for therapeutics start-ups.
• Hertfordshire FuturessupportingStrategic or Co-development PartnerPartners with SBC for the Catalyser programme and broader ecosystem development in Hertfordshire.
• One NucleussupportingGTM or Marketing PartnerFree membership to One Nucleus provided to Lab Hotel occupiers for networking and industry access.
• Centre for Process Innovation (CPI)supportingStrategic or Co-development PartnerPartnered with Genenet Technology for product development support.
• Medicine Discovery CatapultsupportingStrategic or Co-development PartnerPartnered with Genenet Technology for product development support.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Babraham Research Campus: Cambridge-area biotech and life sciences incubator campus operating a similar model of lab/office accommodation plus accelerator programs (e.g. Babraham Accelerator). Directly comparable to SBC as a UK biotech R&D campus with shared facilities and start-up support services.
• BioCity: UK-based life sciences and tech incubator providing lab and office space, accelerator programs (e.g. BioCity Accelerator) and business support to early-stage therapeutics and diagnostics companies. Closest direct competitor in the UK incubator market to SBC's Lab Hotel / Incubator / Accelerator model.
• Cambridge Science Park: Long-established UK science park in Cambridge offering lab and office accommodation to life sciences and tech companies. Direct UK peer to SBC for laboratory-let space within the Golden Triangle.
• Alderley Park: Large former-ICI life sciences campus in Cheshire offering lab space, accelerator (Alderley Park Accelerator) and shared equipment to biotech start-ups and scale-ups. Directly comparable UK biotech incubator with similar Lab Hotel-style facilities.
• Manchester Science Park: UK science park providing office and lab space plus business support to life sciences and tech start-ups, with specific biotech/health programs. Comparable UK regional incubator competitor to SBC.
• Edinburgh BioQuarter: Edinburgh-based life sciences campus co-locating academic, clinical and commercial tenants, including lab space for biotech companies. Comparable UK biology and life sciences incubator model to SBC.
• The Oxford Science Park: Oxford-based science park offering lab and office accommodation to life sciences start-ups and scale-ups within the Golden Triangle. Direct UK peer competing for the same therapeutics tenant base as SBC.
• Chesterford Research Park: Cambridge-region park offering bespoke lab and office space to life sciences SMEs and scale-ups within the Golden Triangle. Comparable high-quality UK biotech property peer to SBC.

Regional players

• London BioScience Innovation Centre (LBIC): Royal Holloway-linked London biotech incubator providing lab and office space plus business support to early-stage life sciences companies. UK peer with overlapping lab-incubation model but central London rather than Stevenage location.

Broad incumbents

• Cell and Gene Therapy Catapult: UK Catapult centre with a £60m manufacturing centre physically located on the SBC campus. While not a direct competitor, it is the dominant UK advanced-therapy manufacturing platform and a key SBC partner/infrastructural anchor; relevant as a broader-incumbent CGT platform operator.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@StevenageCatalyst
• Xx.com/SteBioCat
• Facebookfacebook.com/569129429816047

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stevenage Bioscience Catalyst